A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)
Status:
Completed
Trial end date:
2021-04-09
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of FOY-305 in patients with SARS-CoV-2 infection (COVID-19)
in a placebo-controlled, multicenter, double-blind, randomized, parallel-group comparative
study.